新辅助化疗后乳腺病理完全缓解与腋窝病理完全缓解的关联性
朱久俊， 焦得闯， 乔江华， 王丽娜… - 山东大学学报 …, 2022 - yxbwk.njournal.sdu.edu.cn
… in patients who achieved breast pathologic complete response(pCR)after neoadjuvant
chemotherapy(NAC). Methods The clinical data of 701 breast cancer cases treated with NAC …
chemotherapy(NAC). Methods The clinical data of 701 breast cancer cases treated with NAC …
乳腺组织定位标记夹在乳腺外科中的应用
王昭蕊， 裴静 - 中华乳腺病杂志(电子版), 2020 - zhrxbzz.cma-cmc.com.cn
… Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from
National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J]. J Clin Oncol,2005,23(12):…
National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J]. J Clin Oncol,2005,23(12):…
[PDF][PDF] 早期干预对缺铁性贫血产妇及新生儿的影响
李华 - 齐齐哈尔医学院学报, 2015 - 11871494.s21i.faiusr.com
目的探讨早期干预对缺铁性贫血产妇及新生儿的影响. 方法选择我科2013 年2 月至2014 年3 月
收治的290 例缺铁性贫血孕妇作为研究对象, 按随机数字表法将其随机分为实验组和对照组各…
收治的290 例缺铁性贫血孕妇作为研究对象, 按随机数字表法将其随机分为实验组和对照组各…
乳腺癌前哨淋巴结活组织检查术的临床应用
陈小清， 廖宁 - 中华乳腺病杂志(电子版), 2021 - zhrxbzz.cma-cmc.com.cn
… Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from
National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J]. J Clin Oncol,2005,23(12):…
National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J]. J Clin Oncol,2005,23(12):…
[HTML][HTML] 超声结合钼靶成像及Ki-67 表达对乳腺癌新辅助化疗疗效的预测价值
唐益勇， 李晓琴， 施燕芸… - 中华医学超声杂志 …, 2021 - chaosheng.cma-cmc.com.cn
… The absence of posterior shadowing on ultrasound, absence of mammographic speculation,
and high Ki-67 high could predict the degree of pathological remission in breast cancer …
and high Ki-67 high could predict the degree of pathological remission in breast cancer …
乳腺癌分子分型在多西他赛密集新辅助化疗疗效及预后中的预测价值
刘秋明， 曹亚丽， 吴晓波， 夏勇， 涂剑宏， 欧阳倩雯… - 肿瘤防治研究, 2013 - zlfzyj.com
… Secondary end points were adverse events,pathologic complete response(pCR).ResultsIn …
:preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27[J]…
:preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27[J]…
218 例女性乳腺癌患者行新辅助化疗及伴随分子标志物改变的临床价值
初竹秀， 赵文静， 李小燕， 孔晓丽… - 山东大学学报 …, 2021 - yxbwk.njournal.sdu.edu.cn
… , lymph node metastasis status, molecular typing and other pathological indicators as well
as breast preservation willingness. NAC can change the expressions of ER, PR and Ki-67 in …
as breast preservation willingness. NAC can change the expressions of ER, PR and Ki-67 in …
[HTML][HTML] 新辅助治疗对雌激素受体低表达/人类表皮生长因子受体2 阳性乳腺癌腋窝淋巴结状态的影响
崔世恩， 凌飞海， 黄志华… - 中华普通外科学文献 …, 2020 - zhptwkxwx.cma-cmc.com.cn
… pathological response and influencing factors of axillary lymph nodes in patients with ER-negative/HER2-positive
breast … breast cancer: National Surgical Adjuvant Breast and Bowel …
breast … breast cancer: National Surgical Adjuvant Breast and Bowel …
[PDF][PDF] 乳腺癌新辅助化疗疗效评价体系
邵帅， 李培峰， 柳玉彬， 王哲 - 2012 - biomed.cnjournals.com
… 美国乳腺与肠道外科辅助治疗研究组(National Surgical Adjuvant Breast and Bowel Project,NSABP)自…
A new histological grading system to assess response of breast cancers to primary …
A new histological grading system to assess response of breast cancers to primary …
多柔比星脂质体在乳腺癌辅助化疗中的临床应用
M Zhao, X Ding, J Shen, X Zhang, X Ding… - Journal of Zhejiang …, 2017 - Springer
… In addition, this study also discovered that patients’ pathological response rate was … :
preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J. Clin. …
preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J. Clin. …